2012 Q2 Form 10-Q Financial Statement

#000117891312001354 Filed on May 08, 2012

View on sec.gov

Income Statement

Concept 2012 Q2 2012 Q1 2011 Q1
Revenue $101.0K $230.0K
YoY Change
Cost Of Revenue $0.00 $6.000K
YoY Change
Gross Profit $101.0K $224.0K
YoY Change
Gross Profit Margin 100.0% 97.39%
Selling, General & Admin $1.730M $1.920M $1.150M
YoY Change 30.08% 66.96% 49.35%
% of Gross Profit 1712.87% 857.14%
Research & Development $3.421M $2.145M
YoY Change 59.49% 20.51%
% of Gross Profit 1527.23%
Depreciation & Amortization $130.0K $110.0K $80.00K
YoY Change 44.44% 37.5% 60.0%
% of Gross Profit 128.71% 49.11%
Operating Expenses $4.072M $4.840M $2.699M
YoY Change 6.12% 79.33% 19.42%
Operating Profit -$3.971M -$4.610M -$2.699M
YoY Change 3.49% 70.8%
Interest Expense -$160.0K $440.0K $90.00K
YoY Change -245.45% 388.89% -1000.0%
% of Operating Profit
Other Income/Expense, Net
YoY Change
Pretax Income -$4.140M -$4.170M -$2.610M
YoY Change 10.99% 59.77% 15.49%
Income Tax $0.00 $0.00 $0.00
% Of Pretax Income
Net Earnings -$4.135M -$4.174M -$2.613M
YoY Change 11.01% 59.74% 15.62%
Net Earnings / Revenue -4094.06% -1814.78%
Basic Earnings Per Share
Diluted Earnings Per Share -$0.91 -$0.94 -$0.71
COMMON SHARES
Basic Shares Outstanding 44.82M 44.35M
Diluted Shares Outstanding

Balance Sheet

Concept 2012 Q2 2012 Q1 2011 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments $37.81M $39.54M $44.87M
YoY Change -11.72% -11.88% 2121.29%
Cash & Equivalents $9.389M $11.61M $44.87M
Short-Term Investments $28.42M $27.94M $0.00
Other Short-Term Assets $383.0K $170.0K $210.0K
YoY Change 23.55% -19.05% 425.0%
Inventory
Prepaid Expenses $45.00K $172.0K
Receivables $340.0K $1.740M $540.0K
Other Receivables $0.00 $0.00 $0.00
Total Short-Term Assets $38.19M $41.46M $45.62M
YoY Change -11.79% -9.13% 1808.79%
LONG-TERM ASSETS
Property, Plant & Equipment $5.019M $3.066M $1.940M
YoY Change 140.37% 58.04% 56.45%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments $1.290M $700.0K $180.0K
YoY Change 616.67% 288.89% 0.0%
Other Assets $1.155M $410.0K
YoY Change 181.71% 51.85%
Total Long-Term Assets $9.228M $5.441M $2.530M
YoY Change 239.39% 115.06% 48.82%
TOTAL ASSETS
Total Short-Term Assets $38.19M $41.46M $45.62M
Total Long-Term Assets $9.228M $5.441M $2.530M
Total Assets $47.42M $46.90M $48.15M
YoY Change 3.05% -2.6% 1077.26%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $1.368M $1.529M $1.280M
YoY Change 16.23% 19.45% 103.17%
Accrued Expenses $922.0K $230.0K $110.0K
YoY Change 343.27% 109.09% 83.33%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00 $0.00
YoY Change
Long-Term Debt Due $13.00K
YoY Change -78.33%
Total Short-Term Liabilities $5.522M $4.854M $1.910M
YoY Change 173.64% 154.14% 69.03%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $0.00 $0.00
YoY Change
Other Long-Term Liabilities $4.140M $500.0K
YoY Change 728.0% 51.52%
Total Long-Term Liabilities $4.156M $4.141M $500.0K
YoY Change 621.53% 728.2% 51.52%
TOTAL LIABILITIES
Total Short-Term Liabilities $5.522M $4.854M $1.910M
Total Long-Term Liabilities $4.156M $4.141M $500.0K
Total Liabilities $9.678M $8.995M $2.410M
YoY Change 273.09% 273.24% 65.07%
SHAREHOLDERS EQUITY
Retained Earnings -$65.75M -$61.61M
YoY Change 29.03%
Common Stock $0.00 $0.00
YoY Change
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $37.74M $37.90M $45.75M
YoY Change
Total Liabilities & Shareholders Equity $47.42M $46.90M $48.15M
YoY Change 3.05% -2.6% 1077.26%

Cashflow Statement

Concept 2012 Q2 2012 Q1 2011 Q1
OPERATING ACTIVITIES
Net Income -$4.135M -$4.174M -$2.613M
YoY Change 11.01% 59.74% 15.62%
Depreciation, Depletion And Amortization $130.0K $110.0K $80.00K
YoY Change 44.44% 37.5% 60.0%
Cash From Operating Activities -$930.0K -$2.520M -$1.380M
YoY Change -56.94% 82.61% -25.0%
INVESTING ACTIVITIES
Capital Expenditures $170.0K $310.0K $110.0K
YoY Change -41.38% 181.82% 83.33%
Acquisitions
YoY Change
Other Investing Activities -$1.360M $7.780M $0.00
YoY Change -100.0%
Cash From Investing Activities -$1.520M $7.450M -$110.0K
YoY Change 406.67% -6872.73% -107.1%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 230.0K 0.000 41.61M
YoY Change -45.24% -100.0% 138600.0%
NET CHANGE
Cash From Operating Activities -930.0K -2.520M -1.380M
Cash From Investing Activities -1.520M 7.450M -110.0K
Cash From Financing Activities 230.0K 0.000 41.61M
Net Change In Cash -2.220M 4.930M 40.12M
YoY Change 8.82% -87.71% -15530.77%
FREE CASH FLOW
Cash From Operating Activities -$930.0K -$2.520M -$1.380M
Capital Expenditures $170.0K $310.0K $110.0K
Free Cash Flow -$1.100M -$2.830M -$1.490M
YoY Change -55.1% 89.93% -21.58%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
dei Amendment Flag
AmendmentFlag
false
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--06-30
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q3
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2012
dei Document Period End Date
DocumentPeriodEndDate
2012-03-31
dei Document Type
DocumentType
10-Q
dei Entity Central Index Key
EntityCentralIndexKey
0001158780
CY2012Q2 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
44820485
dei Entity Filer Category
EntityFilerCategory
Smaller Reporting Company
dei Entity Registrant Name
EntityRegistrantName
PLURISTEM THERAPEUTICS INC
psti Amortization Of Discount And Premium And Changes In Accrued Interest From Marketable Securities
AmortizationOfDiscountAndPremiumAndChangesInAccruedInterestFromMarketableSecurities
-174000 USD
psti Amortization Of Discount And Premium And Changes In Accrued Interest From Marketable Securities
AmortizationOfDiscountAndPremiumAndChangesInAccruedInterestFromMarketableSecurities
USD
CY2011 psti Amortization Of Discount And Premium And Changes In Accrued Interest From Marketable Securities
AmortizationOfDiscountAndPremiumAndChangesInAccruedInterestFromMarketableSecurities
USD
psti Exercise Of Warrants By Investors And Finders
ExerciseOfWarrantsByInvestorsAndFinders
383000 USD
psti Exercise Of Warrants By Investors And Finders
ExerciseOfWarrantsByInvestorsAndFinders
3202000 USD
CY2011 psti Exercise Of Warrants By Investors And Finders
ExerciseOfWarrantsByInvestorsAndFinders
3593000 USD
psti Financial Income Expense Net
FinancialIncomeExpenseNet
401000 USD
psti Financial Income Expense Net
FinancialIncomeExpenseNet
154000 USD
CY2012Q1 psti Financial Income Expense Net
FinancialIncomeExpenseNet
436000 USD
CY2011Q1 psti Financial Income Expense Net
FinancialIncomeExpenseNet
86000 USD
CY2011 psti Financial Income Expense Net
FinancialIncomeExpenseNet
266000 USD
psti Issuance Of Common Stock And Warrants Related To February2011 Agreement
IssuanceOfCommonStockAndWarrantsRelatedToFebruary2011Agreement
38142000 USD
CY2011 psti Issuance Of Common Stock And Warrants Related To February2011 Agreement
IssuanceOfCommonStockAndWarrantsRelatedToFebruary2011Agreement
38142000 USD
psti Issuance Of Common Stock And Warrants Related To October2010 Agreement
IssuanceOfCommonStockAndWarrantsRelatedToOctober2010Agreement
5006000 USD
CY2011 psti Issuance Of Common Stock And Warrants Related To October2010 Agreement
IssuanceOfCommonStockAndWarrantsRelatedToOctober2010Agreement
5006000 USD
psti Issuance Of Common Stock Related To Investors Relation Agreements
IssuanceOfCommonStockRelatedToInvestorsRelationAgreements
155000 USD
CY2011 psti Issuance Of Common Stock Related To Investors Relation Agreements
IssuanceOfCommonStockRelatedToInvestorsRelationAgreements
155000 USD
psti Issuance Of Shares In Consideration Of Leasehold Improvements
IssuanceOfSharesInConsiderationOfLeaseholdImprovements
1155000 USD
psti Issuance Of Shares In Consideration Of Leasehold Improvements
IssuanceOfSharesInConsiderationOfLeaseholdImprovements
USD
CY2011 psti Issuance Of Shares In Consideration Of Leasehold Improvements
IssuanceOfSharesInConsiderationOfLeaseholdImprovements
USD
psti Linkage Differences And Interest On Long Term Restricted Lease Deposit
LinkageDifferencesAndInterestOnLongTermRestrictedLeaseDeposit
4000 USD
psti Linkage Differences And Interest On Long Term Restricted Lease Deposit
LinkageDifferencesAndInterestOnLongTermRestrictedLeaseDeposit
-3000 USD
CY2011 psti Linkage Differences And Interest On Long Term Restricted Lease Deposit
LinkageDifferencesAndInterestOnLongTermRestrictedLeaseDeposit
-4000 USD
psti Linkage Differences And Interest On Short Term Restricted Lease Deposit
LinkageDifferencesAndInterestOnShortTermRestrictedLeaseDeposit
15000 USD
psti Linkage Differences And Interest On Short Term Restricted Lease Deposit
LinkageDifferencesAndInterestOnShortTermRestrictedLeaseDeposit
USD
CY2011 psti Linkage Differences And Interest On Short Term Restricted Lease Deposit
LinkageDifferencesAndInterestOnShortTermRestrictedLeaseDeposit
USD
psti Participation By Office Of Chief Scientist And Other Parties
ParticipationByOfficeOfChiefScientistAndOtherParties
-2432000 USD
psti Participation By Office Of Chief Scientist And Other Parties
ParticipationByOfficeOfChiefScientistAndOtherParties
-1709000 USD
CY2012Q1 psti Participation By Office Of Chief Scientist And Other Parties
ParticipationByOfficeOfChiefScientistAndOtherParties
-511000 USD
CY2011Q1 psti Participation By Office Of Chief Scientist And Other Parties
ParticipationByOfficeOfChiefScientistAndOtherParties
-598000 USD
CY2011 psti Participation By Office Of Chief Scientist And Other Parties
ParticipationByOfficeOfChiefScientistAndOtherParties
-1682000 USD
psti Purchase Of Property And Equipment In Credit
PurchaseOfPropertyAndEquipmentInCredit
100000 USD
psti Purchase Of Property And Equipment In Credit
PurchaseOfPropertyAndEquipmentInCredit
168000 USD
CY2011 psti Purchase Of Property And Equipment In Credit
PurchaseOfPropertyAndEquipmentInCredit
123000 USD
psti Research And Development Expenses Net
ResearchAndDevelopmentExpensesNet
6839000 USD
psti Research And Development Expenses Net
ResearchAndDevelopmentExpensesNet
4123000 USD
CY2012Q1 psti Research And Development Expenses Net
ResearchAndDevelopmentExpensesNet
2916000 USD
CY2011 psti Share Based Compensation To Employees Directors And Non Employees
ShareBasedCompensationToEmployeesDirectorsAndNonEmployees
3325000 USD
psti Stock Based Compensation To Employees Directors And Non Employees Consultants
StockBasedCompensationToEmployeesDirectorsAndNonEmployeesConsultants
4689000 USD
psti Stock Based Compensation To Employees Directors And Non Employees Consultants
StockBasedCompensationToEmployeesDirectorsAndNonEmployeesConsultants
2336000 USD
CY2011 psti Stock Based Compensation To Employees Directors And Non Employees Consultants
StockBasedCompensationToEmployeesDirectorsAndNonEmployeesConsultants
3325000 USD
psti Weighted Average Number Of Shares Outstanding Basic And Diluted Duration
WeightedAverageNumberOfSharesOutstandingBasicAndDilutedDuration
43585104
CY2011Q1 psti Research And Development Expenses Net
ResearchAndDevelopmentExpensesNet
1547000 USD
CY2011 psti Research And Development Expenses Net
ResearchAndDevelopmentExpensesNet
6629000 USD
psti Share Based Compensation To Employees Directors And Non Employees
ShareBasedCompensationToEmployeesDirectorsAndNonEmployees
3533000 USD
psti Share Based Compensation To Employees Directors And Non Employees
ShareBasedCompensationToEmployeesDirectorsAndNonEmployees
2336000 USD
psti Weighted Average Number Of Shares Outstanding Basic And Diluted Duration
WeightedAverageNumberOfSharesOutstandingBasicAndDilutedDuration
27894392
CY2012Q1 psti Weighted Average Number Of Shares Outstanding Basic And Diluted Duration
WeightedAverageNumberOfSharesOutstandingBasicAndDilutedDuration
44328201
CY2011Q1 psti Weighted Average Number Of Shares Outstanding Basic And Diluted Duration
WeightedAverageNumberOfSharesOutstandingBasicAndDilutedDuration
36676721
CY2011 psti Weighted Average Number Of Shares Outstanding Basic And Diluted Duration
WeightedAverageNumberOfSharesOutstandingBasicAndDilutedDuration
31198825
CY2011Q2 us-gaap Accounts Payable Current
AccountsPayableCurrent
1177000 USD
CY2012Q1 us-gaap Accounts Payable Current
AccountsPayableCurrent
1529000 USD
CY2011Q2 us-gaap Accounts Payable Other Current
AccountsPayableOtherCurrent
633000 USD
CY2012Q1 us-gaap Accounts Payable Other Current
AccountsPayableOtherCurrent
663000 USD
CY2011Q2 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
208000 USD
CY2012Q1 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
230000 USD
CY2011Q2 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
USD
CY2012Q1 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
52000 USD
CY2011Q2 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
94375000 USD
CY2012Q1 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
99461000 USD
us-gaap Asset Impairment Charges
AssetImpairmentCharges
USD
us-gaap Asset Impairment Charges
AssetImpairmentCharges
USD
CY2011 us-gaap Asset Impairment Charges
AssetImpairmentCharges
11000 USD
CY2011Q2 us-gaap Assets
Assets
46016000 USD
CY2012Q1 us-gaap Assets
Assets
46896000 USD
CY2011Q2 us-gaap Assets Current
AssetsCurrent
43297000 USD
CY2012Q1 us-gaap Assets Current
AssetsCurrent
41455000 USD
CY2011Q2 us-gaap Assets Noncurrent
AssetsNoncurrent
2719000 USD
CY2012Q1 us-gaap Assets Noncurrent
AssetsNoncurrent
5441000 USD
CY2011Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
42829000 USD
CY2012Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
11605000 USD
CY2010Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
1583000 USD
CY2011Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
44866000 USD
us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
-31224000 USD
us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
43283000 USD
CY2011 us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
41246000 USD
CY2011Q2 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
USD
CY2012Q1 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
USD
CY2011Q1 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
1152000 USD
CY2011 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
4485000 USD
CY2011Q2 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.00001
CY2012Q1 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.00001
CY2011Q2 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
100000000
CY2012Q1 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
100000000
CY2011Q2 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
42443185
CY2012Q1 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
44516175
CY2011Q2 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
42443185
CY2012Q1 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
44516175
CY2011Q2 us-gaap Common Stock Value
CommonStockValue
USD
CY2012Q1 us-gaap Common Stock Value
CommonStockValue
USD
CY2011Q2 us-gaap Customer Advances Current
CustomerAdvancesCurrent
USD
CY2012Q1 us-gaap Customer Advances Current
CustomerAdvancesCurrent
1509000 USD
CY2011Q2 us-gaap Deferred Revenue Current
DeferredRevenueCurrent
USD
CY2012Q1 us-gaap Deferred Revenue Current
DeferredRevenueCurrent
923000 USD
CY2011Q2 us-gaap Deferred Revenue Noncurrent
DeferredRevenueNoncurrent
USD
CY2012Q1 us-gaap Deferred Revenue Noncurrent
DeferredRevenueNoncurrent
3462000 USD
CY2011Q2 us-gaap Defined Benefit Plan Assets For Plan Benefits Noncurrent
DefinedBenefitPlanAssetsForPlanBenefitsNoncurrent
452000 USD
CY2012Q1 us-gaap Defined Benefit Plan Assets For Plan Benefits Noncurrent
DefinedBenefitPlanAssetsForPlanBenefitsNoncurrent
525000 USD
CY2011Q2 us-gaap Deposits Assets Noncurrent
DepositsAssetsNoncurrent
179000 USD
CY2012Q1 us-gaap Deposits Assets Noncurrent
DepositsAssetsNoncurrent
695000 USD
us-gaap Depreciation
Depreciation
312000 USD
us-gaap Depreciation
Depreciation
224000 USD
CY2011 us-gaap Depreciation
Depreciation
312000 USD
us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.24
us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.26
CY2012Q1 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.09
CY2011Q1 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.07
CY2011 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.35
us-gaap Gain Loss On Sale Of Property Plant Equipment
GainLossOnSaleOfPropertyPlantEquipment
USD
us-gaap Gain Loss On Sale Of Property Plant Equipment
GainLossOnSaleOfPropertyPlantEquipment
-8000 USD
CY2011 us-gaap Gain Loss On Sale Of Property Plant Equipment
GainLossOnSaleOfPropertyPlantEquipment
-8000 USD
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
4836000 USD
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
3154000 USD
CY2012Q1 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
1924000 USD
us-gaap Income Taxes Paid
IncomeTaxesPaid
12000 USD
us-gaap Marketable Securities Unrealized Gain Loss Excluding Other Than Temporary Impairments
MarketableSecuritiesUnrealizedGainLossExcludingOtherThanTemporaryImpairments
USD
CY2011 us-gaap Marketable Securities Unrealized Gain Loss Excluding Other Than Temporary Impairments
MarketableSecuritiesUnrealizedGainLossExcludingOtherThanTemporaryImpairments
USD
us-gaap Income Taxes Paid
IncomeTaxesPaid
9000 USD
CY2011 us-gaap Income Taxes Paid
IncomeTaxesPaid
11000 USD
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
375000 USD
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
516000 USD
CY2011 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
455000 USD
us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
52000 USD
us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
156000 USD
CY2011 us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
375000 USD
us-gaap Increase Decrease In Accrued Interest Receivable Net
IncreaseDecreaseInAccruedInterestReceivableNet
284000 USD
us-gaap Increase Decrease In Accrued Interest Receivable Net
IncreaseDecreaseInAccruedInterestReceivableNet
-15000 USD
CY2011 us-gaap Increase Decrease In Accrued Interest Receivable Net
IncreaseDecreaseInAccruedInterestReceivableNet
-15000 USD
us-gaap Increase Decrease In Customer Advances
IncreaseDecreaseInCustomerAdvances
1509000 USD
us-gaap Increase Decrease In Customer Advances
IncreaseDecreaseInCustomerAdvances
USD
CY2011 us-gaap Increase Decrease In Customer Advances
IncreaseDecreaseInCustomerAdvances
USD
us-gaap Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
4385000 USD
us-gaap Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
USD
CY2011 us-gaap Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
USD
us-gaap Increase Decrease In Other Receivables
IncreaseDecreaseInOtherReceivables
1586000 USD
us-gaap Increase Decrease In Other Receivables
IncreaseDecreaseInOtherReceivables
-265000 USD
CY2011 us-gaap Increase Decrease In Other Receivables
IncreaseDecreaseInOtherReceivables
-656000 USD
us-gaap Increase Decrease In Pension And Postretirement Obligations
IncreaseDecreaseInPensionAndPostretirementObligations
30000 USD
us-gaap Increase Decrease In Pension And Postretirement Obligations
IncreaseDecreaseInPensionAndPostretirementObligations
27000 USD
CY2011 us-gaap Increase Decrease In Pension And Postretirement Obligations
IncreaseDecreaseInPensionAndPostretirementObligations
58000 USD
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
-142000 USD
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
172000 USD
CY2011 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
273000 USD
us-gaap Increase Decrease In Time Deposits
IncreaseDecreaseInTimeDeposits
-21627000 USD
us-gaap Increase Decrease In Time Deposits
IncreaseDecreaseInTimeDeposits
USD
CY2011 us-gaap Increase Decrease In Time Deposits
IncreaseDecreaseInTimeDeposits
USD
us-gaap Issuance Of Stock And Warrants For Services Or Claims
IssuanceOfStockAndWarrantsForServicesOrClaims
1000 USD
us-gaap Issuance Of Stock And Warrants For Services Or Claims
IssuanceOfStockAndWarrantsForServicesOrClaims
155000 USD
CY2011 us-gaap Issuance Of Stock And Warrants For Services Or Claims
IssuanceOfStockAndWarrantsForServicesOrClaims
155000 USD
CY2011Q2 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
46016000 USD
CY2012Q1 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
46896000 USD
CY2011Q2 us-gaap Liabilities Current
LiabilitiesCurrent
2018000 USD
CY2012Q1 us-gaap Liabilities Current
LiabilitiesCurrent
4854000 USD
CY2011Q2 us-gaap Liabilities Noncurrent
LiabilitiesNoncurrent
576000 USD
CY2012Q1 us-gaap Liabilities Noncurrent
LiabilitiesNoncurrent
4141000 USD
CY2011Q2 us-gaap Marketable Securities Current
MarketableSecuritiesCurrent
USD
CY2012Q1 us-gaap Marketable Securities Current
MarketableSecuritiesCurrent
6042000 USD
us-gaap Marketable Securities Unrealized Gain Loss Excluding Other Than Temporary Impairments
MarketableSecuritiesUnrealizedGainLossExcludingOtherThanTemporaryImpairments
52000 USD
us-gaap Net Income Loss
NetIncomeLoss
-10659000 USD
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
397000 USD
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
46624000 USD
CY2011 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
47037000 USD
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-29276000 USD
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
255000 USD
CY2011 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-36000 USD
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-2345000 USD
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-3596000 USD
CY2011 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-5755000 USD
us-gaap Net Income Loss
NetIncomeLoss
-7123000 USD
CY2012Q1 us-gaap Net Income Loss
NetIncomeLoss
-4174000 USD
CY2011Q1 us-gaap Net Income Loss
NetIncomeLoss
-2613000 USD
CY2011 us-gaap Net Income Loss
NetIncomeLoss
-10848000 USD
CY2011Q2 us-gaap Nontrade Receivables Current
NontradeReceivablesCurrent
USD
CY2012Q1 us-gaap Nontrade Receivables Current
NontradeReceivablesCurrent
1529000 USD
us-gaap Operating Income Loss
OperatingIncomeLoss
-11060000 USD
us-gaap Operating Income Loss
OperatingIncomeLoss
-7277000 USD
CY2012Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
-4610000 USD
CY2011Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
-2699000 USD
CY2011 us-gaap Operating Income Loss
OperatingIncomeLoss
-11114000 USD
CY2011Q2 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
USD
CY2012Q1 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
1155000 USD
us-gaap Other Comprehensive Income Availableforsale Securities Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent
52000 USD
CY2011Q1 us-gaap Payments Of Stock Issuance Costs
PaymentsOfStockIssuanceCosts
2970000 USD
CY2010Q4 us-gaap Payments Of Stock Issuance Costs
PaymentsOfStockIssuanceCosts
244000 USD
us-gaap Payments To Acquire Available For Sale Securities Equity
PaymentsToAcquireAvailableForSaleSecuritiesEquity
6566000 USD
us-gaap Payments To Acquire Available For Sale Securities Equity
PaymentsToAcquireAvailableForSaleSecuritiesEquity
USD
CY2011 us-gaap Payments To Acquire Available For Sale Securities Equity
PaymentsToAcquireAvailableForSaleSecuritiesEquity
USD
us-gaap Payments To Acquire Investments
PaymentsToAcquireInvestments
526000 USD
us-gaap Payments To Acquire Investments
PaymentsToAcquireInvestments
12000 USD
CY2011 us-gaap Payments To Acquire Investments
PaymentsToAcquireInvestments
14000 USD
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
1313000 USD
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
672000 USD
CY2011 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
962000 USD
CY2011Q2 us-gaap Postemployment Benefits Liability Noncurrent
PostemploymentBenefitsLiabilityNoncurrent
576000 USD
CY2012Q1 us-gaap Postemployment Benefits Liability Noncurrent
PostemploymentBenefitsLiabilityNoncurrent
679000 USD
CY2011Q2 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
314000 USD
CY2012Q1 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
172000 USD
us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
USD
us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
43400000 USD
CY2011 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
68000 USD
CY2011 us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
43400000 USD
us-gaap Proceeds From Issuance Of Shares Under Incentive And Share Based Compensation Plans Including Stock Options
ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions
397000 USD
us-gaap Proceeds From Issuance Of Shares Under Incentive And Share Based Compensation Plans Including Stock Options
ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions
3248000 USD
CY2011 us-gaap Proceeds From Issuance Of Shares Under Incentive And Share Based Compensation Plans Including Stock Options
ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions
3661000 USD
us-gaap Proceeds From Maturities Prepayments And Calls Of Available For Sale Securities
ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities
750000 USD
us-gaap Proceeds From Maturities Prepayments And Calls Of Available For Sale Securities
ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities
USD
CY2011 us-gaap Proceeds From Maturities Prepayments And Calls Of Available For Sale Securities
ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities
USD
us-gaap Proceeds From Sale Of Property Plant And Equipment
ProceedsFromSaleOfPropertyPlantAndEquipment
USD
us-gaap Proceeds From Sale Of Property Plant And Equipment
ProceedsFromSaleOfPropertyPlantAndEquipment
28000 USD
CY2011 us-gaap Proceeds From Sale Of Property Plant And Equipment
ProceedsFromSaleOfPropertyPlantAndEquipment
29000 USD
us-gaap Proceeds From Sale Of Restricted Investments
ProceedsFromSaleOfRestrictedInvestments
6000 USD
us-gaap Proceeds From Sale Of Restricted Investments
ProceedsFromSaleOfRestrictedInvestments
13000 USD
CY2011 us-gaap Proceeds From Sale Of Restricted Investments
ProceedsFromSaleOfRestrictedInvestments
13000 USD
us-gaap Proceeds From Sale Of Short Term Investments
ProceedsFromSaleOfShortTermInvestments
USD
us-gaap Proceeds From Sale Of Short Term Investments
ProceedsFromSaleOfShortTermInvestments
898000 USD
CY2011 us-gaap Proceeds From Sale Of Short Term Investments
ProceedsFromSaleOfShortTermInvestments
898000 USD
CY2011Q2 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
2088000 USD
CY2012Q1 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
3066000 USD
CY2011Q2 us-gaap Receivables Net Current
ReceivablesNetCurrent
154000 USD
CY2012Q1 us-gaap Receivables Net Current
ReceivablesNetCurrent
211000 USD
us-gaap Repayments Of Long Term Debt
RepaymentsOfLongTermDebt
USD
us-gaap Repayments Of Long Term Debt
RepaymentsOfLongTermDebt
24000 USD
CY2011 us-gaap Repayments Of Long Term Debt
RepaymentsOfLongTermDebt
24000 USD
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
9271000 USD
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
5832000 USD
CY2012Q1 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
3427000 USD
CY2011Q1 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
2145000 USD
CY2011 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
8311000 USD
CY2011Q2 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-50953000 USD
CY2012Q1 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-61612000 USD
us-gaap Revenues
Revenues
615000 USD
us-gaap Revenues
Revenues
USD
CY2012Q1 us-gaap Revenues
Revenues
230000 USD
CY2011Q1 us-gaap Revenues
Revenues
USD
CY2011 us-gaap Revenues
Revenues
USD
CY2011Q2 us-gaap Short Term Investments
ShortTermInvestments
USD
CY2012Q1 us-gaap Short Term Investments
ShortTermInvestments
21896000 USD
CY2011Q2 us-gaap Stockholders Equity
StockholdersEquity
43422000 USD
CY2012Q1 us-gaap Stockholders Equity
StockholdersEquity
37901000 USD
CY2010Q2 us-gaap Stockholders Equity
StockholdersEquity
3981000 USD
CY2011Q1 us-gaap Stockholders Equity
StockholdersEquity
45745000 USD
us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
14000 USD
us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
46000 USD

Files In Submission

Name View Source Status
0001178913-12-001354-index-headers.html Edgar Link pending
0001178913-12-001354-index.html Edgar Link pending
0001178913-12-001354.txt Edgar Link pending
0001178913-12-001354-xbrl.zip Edgar Link pending
exhibit_31-1.htm Edgar Link pending
exhibit_31-2.htm Edgar Link pending
exhibit_32-1.htm Edgar Link pending
exhibit_32-2.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xls Edgar Link pending
psti-20120331.xml Edgar Link completed
psti-20120331.xsd Edgar Link pending
psti-20120331_cal.xml Edgar Link unprocessable
psti-20120331_def.xml Edgar Link unprocessable
psti-20120331_lab.xml Edgar Link unprocessable
psti-20120331_pre.xml Edgar Link unprocessable
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R2.htm Edgar Link pending
R3.htm Edgar Link pending
R4.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
zk1211424.htm Edgar Link pending